These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
723 related articles for article (PubMed ID: 15135683)
21. Axillary regional recurrence after sentinel lymph node biopsy for breast cancer. Rosing DK; Dauphine CE; Vargas MP; Gonzalez K; Burla M; Kaufmann P; Vargas HI Am Surg; 2006 Oct; 72(10):939-42. PubMed ID: 17058740 [TBL] [Abstract][Full Text] [Related]
22. The effect of dedicated breast surgeons on the short-term outcomes in breast cancer. Zork NM; Komenaka IK; Pennington RE; Bowling MW; Norton LE; Clare SE; Goulet RJ Ann Surg; 2008 Aug; 248(2):280-5. PubMed ID: 18650639 [TBL] [Abstract][Full Text] [Related]
23. Selecting patients for breast-conserving therapy: the importance of lobular histology. Morrow M; Keeney K; Scholtens D; Wei J; Steel J; Khan SA Cancer; 2006 Jun; 106(12):2563-8. PubMed ID: 16683225 [TBL] [Abstract][Full Text] [Related]
25. Feasibility of breast-conserving surgery for patients with breast carcinoma associated with nipple discharge. Cabioglu N; Krishnamurthy S; Kuerer HM; Hunt KK; Singletary SE; Meric-Bernstam F; Ross MI; Feig BW; Ames FC; Babiera GV Cancer; 2004 Aug; 101(3):508-17. PubMed ID: 15274063 [TBL] [Abstract][Full Text] [Related]
26. The impact of lobular carcinoma in situ in association with invasive breast cancer on the rate of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy. Jolly S; Kestin LL; Goldstein NS; Vicini FA Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):365-71. PubMed ID: 16965988 [TBL] [Abstract][Full Text] [Related]
27. Patient age and positive margins are predictive factors of residual tumor on mastectomy specimen after conservative treatment for breast cancer. Voguet L; Hébert T; Levêque J; Acker O; Mesbah H; Marret H; Porée P; Body G Breast; 2009 Aug; 18(4):233-7. PubMed ID: 19628389 [TBL] [Abstract][Full Text] [Related]
28. Breast conservation therapy for invasive lobular carcinoma: the impact of lobular carcinoma in situ in the surgical specimen on local recurrence and axillary node status. Stolier AJ; Barre G; Bolton JS; Fuhrman GM; Looney S Am Surg; 2004 Sep; 70(9):818-21. PubMed ID: 15481302 [TBL] [Abstract][Full Text] [Related]
29. Sentinel node biopsy in elderly breast cancer patients. Gennari R; Rotmensz N; Perego E; dos Santos G; Veronesi U Surg Oncol; 2004 Dec; 13(4):193-6. PubMed ID: 15615656 [TBL] [Abstract][Full Text] [Related]
30. Arm and shoulder morbidity in breast cancer patients after breast-conserving therapy versus mastectomy. Nesvold IL; Dahl AA; Løkkevik E; Marit Mengshoel A; Fosså SD Acta Oncol; 2008; 47(5):835-42. PubMed ID: 18568481 [TBL] [Abstract][Full Text] [Related]
31. Improving local control with breast-conserving therapy: a 27-year single-institution experience. Cabioglu N; Hunt KK; Buchholz TA; Mirza N; Singletary SE; Kuerer HM; Babiera GV; Ames FC; Sahin AA; Meric-Bernstam F Cancer; 2005 Jul; 104(1):20-9. PubMed ID: 15912514 [TBL] [Abstract][Full Text] [Related]
32. Factors predisposing to cavity margin positivity following conservation surgery for breast cancer. Keskek M; Kothari M; Ardehali B; Betambeau N; Nasiri N; Gui GP Eur J Surg Oncol; 2004 Dec; 30(10):1058-64. PubMed ID: 15522551 [TBL] [Abstract][Full Text] [Related]
33. Quality measures for breast cancer surgery: initial validation of feasibility and assessment of variation among surgeons. McCahill LE; Privette A; James T; Sheehey-Jones J; Ratliff J; Majercik D; Krag DN; Stanley M; Harlow S Arch Surg; 2009 May; 144(5):455-62; discussion 462-3. PubMed ID: 19451489 [TBL] [Abstract][Full Text] [Related]
34. Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer. Katz A; Smith BL; Golshan M; Niemierko A; Kobayashi W; Raad RA; Kelada A; Rizk L; Wong JS; Bellon JR; Gadd M; Specht M; Taghian AG J Clin Oncol; 2008 May; 26(13):2093-8. PubMed ID: 18445838 [TBL] [Abstract][Full Text] [Related]
35. Factors associated with re-excision in patients with early-stage breast cancer treated with breast conservation therapy. Sanchez C; Brem RF; McSwain AP; Rapelyea JA; Torrente J; Teal CB Am Surg; 2010 Mar; 76(3):331-4. PubMed ID: 20349668 [TBL] [Abstract][Full Text] [Related]
36. Lymphatic mapping and sentinel lymph node biopsy for patients with local recurrence after breast-conservation therapy. Newman EA; Cimmino VM; Sabel MS; Diehl KM; Frey KA; Chang AE; Newman LA Ann Surg Oncol; 2006 Jan; 13(1):52-7. PubMed ID: 16372155 [TBL] [Abstract][Full Text] [Related]
37. Optimal treatment of multiple ipsilateral primary breast cancers. Carpenter S; Fraser J; Fleming M; Gray R; Halyard M; Pockaj B Am J Surg; 2008 Oct; 196(4):530-6. PubMed ID: 18809057 [TBL] [Abstract][Full Text] [Related]
38. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients? Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642 [TBL] [Abstract][Full Text] [Related]
39. Sentinel node mapping for breast cancer: the operative experience of a breast surgeon in a rural community. Davit FE; Gatmaitan P; Garguilo G Am Surg; 2008 May; 74(5):423-7. PubMed ID: 18481500 [TBL] [Abstract][Full Text] [Related]
40. Intra-operative touch preparation cytology; does it have a role in re-excision lumpectomy? Valdes EK; Boolbol SK; Cohen JM; Feldman SM Ann Surg Oncol; 2007 Mar; 14(3):1045-50. PubMed ID: 17206481 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]